Evidence map›Paper›PMID 38485951›Full record

ArticleNature communications2024

Regulation of meiotic telomere dynamics through membrane fluidity promoted by AdipoR2-ELOVL2.

Jingjing Zhang, Mario Ruiz, Per-Olof Bergh, Marcus Henricsson, Nena Stojanović, Ranjan Devkota, Marius Henn, Mohammad Bohlooly-Y, Abrahan Hernández-Hernández, Manfred Alsheimer and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Jingjing ZhangDepartment of Chemistry and Molecular Biology, University of Gothenburg, 41390, Gothenburg, Sweden.
Mario RuizDepartment of Chemistry and Molecular Biology, University of Gothenburg, 41390, Gothenburg, Sweden.
Per-Olof BerghDepartment of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, 41467, Gothenburg, Sweden.ORCID 0000-0001-9993-6965
Marcus HenricssonDepartment of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, 41467, Gothenburg, Sweden.ORCID 0000-0002-4202-0339
Nena StojanovićDepartment of Chemistry and Molecular Biology, University of Gothenburg, 41390, Gothenburg, Sweden.
Ranjan DevkotaDepartment of Chemistry and Molecular Biology, University of Gothenburg, 41390, Gothenburg, Sweden.
Marius HennDepartment of Cell and Developmental Biology, Biocenter, University of Würzburg, 97074, Würzburg, Germany.
Mohammad Bohlooly-YDiscovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Abrahan Hernández-HernándezDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Manfred AlsheimerDepartment of Cell and Developmental Biology, Biocenter, University of Würzburg, 97074, Würzburg, Germany.ORCID 0000-0002-6646-556X
Jan BorénDepartment of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, 41467, Gothenburg, Sweden.ORCID 0000-0003-0786-8091
Marc PilonDepartment of Chemistry and Molecular Biology, University of Gothenburg, 41390, Gothenburg, Sweden. marc.pilon@cmb.gu.se.ORCID 0000-0003-3919-2882
Hiroki ShibuyaDepartment of Chemistry and Molecular Biology, University of Gothenburg, 41390, Gothenburg, Sweden. hiroki.shibuya@riken.jp.ORCID 0000-0002-3400-0741
University of Gothenburg · SEUniversity of Würzburg · DEAstraZeneca (Sweden) · SERIKEN Center for Biosystems Dynamics Research · JPScience for Life Laboratory · SE

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 426173797 (INST 93/1003-1 FUGG)Deutsche Forschungsgemeinschaft (German Research Foundation) Al 1090/4-2EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) StG-801659Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) KAW2019.0180Vetenskapsrådet (Swedish Research Council) 2018-03426
6 · The paper itself

Abstract

The cellular membrane in male meiotic germ cells contains a unique class of phospholipids and sphingolipids that is required for male reproduction. Here, we show that a conserved membrane fluidity sensor, AdipoR2, regulates the meiosis-specific lipidome in mouse testes by promoting the synthesis of sphingolipids containing very-long-chain polyunsaturated fatty acids (VLC-PUFAs). AdipoR2 upregulates the expression of a fatty acid elongase, ELOVL2, both transcriptionally and post-transcriptionally, to synthesize VLC-PUFA. The depletion of VLC-PUFAs and subsequent accumulation of palmitic acid in AdipoR2 knockout testes stiffens the cellular membrane and causes the invagination of the nuclear envelope. This condition impairs the nuclear peripheral distribution of meiotic telomeres, leading to errors in homologous synapsis and recombination. Further, the stiffened membrane impairs the formation of intercellular bridges and the germ cell syncytium, which disrupts the orderly arrangement of cell types within the seminiferous tubules. According to our findings we propose a framework in which the highly-fluid membrane microenvironment shaped by AdipoR2-ELOVL2 underpins meiosis-specific chromosome dynamics in testes.

Indexed as

Membrane FluidityTelomereAnimalsCarrier ProteinsFatty Acid ElongasesMaleMeiosisMiceNuclear EnvelopeReceptors, AdiponectinSphingolipidsadiponectin receptor 2, mouseCarrier ProteinsELOVL2 protein, mouseFatty Acid ElongasesReceptors, AdiponectinSphingolipids

Identifiers

PMID38485951
PMCPMC10940294
OpenAlexW4392807090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.